Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 41Unknown 9Recruiting 9Active not recruiting 9Terminated 4Withdrawn 3Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 4INDUSTRY 4NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Hemangioma 2Prostatic Neoplasms 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × Prednisolone × Clear all
NCT02125617 2026-01-14

uPARCRPC

Rigshospitalet, Denmark

Terminated
3 enrolled
Genitourinary

Prostatic Neoplasms

NCT00637832 2022-01-06

Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma

University of Southampton

Phase 2 Terminated
1 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT01074437 2018-10-04

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Seattle Children's Hospital

Phase 2 Terminated
9 enrolled 5 charts

Hemangioma

NCT00967226 2016-02-24

Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas

Children's National Research Institute

Phase 2 Terminated
19 enrolled 25 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡